Comparison of the Effectiveness of Percutaneous Coronary Intervention with Everolimus-eluting Stents on Left-main in Women vs Men
Everolimus-eluting stents are largely used for left main (LM) percutaneous coronary interventions (PCI) . Long-term follow-up of patients undergoing LM PCI in a real world clinical setting, in particular women, have been scarcely reported. Consecutive patients undergoing unprotected LM PCI with EES at a single Institution from December 2006 to April 2016 were included. Main outcome assessed was the occurrence of major adverse cardiovascular events (MACE) as a composite of death, myocardial infarction or target lesion revascularization at follow-up.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Daniela Trabattoni, Giovanni Teruzzi, Piero Montorsi, Franco Fabbiocchi, Sebastiano Gili, Giuseppe Calligaris, Luca Grancini, Stefano Galli, Paolo Ravagnani, Antonio Bartorelli Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Coronary Angioplasty | Heart | Heart Attack | Percutaneous Coronary Intervention | Women